Please ensure Javascript is enabled for purposes of website accessibility

pfizer

Gaithersburg-based Novavax Inc. is shown in 2023. (File photo)
Jan 21, 2026

MD-based Novavax signs agreement with Pfizer for vaccine development

Maryland-based Novavax signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to vaccines.

This photo provided by Pfizer in August 2024 shows a packaging for the company's updated COVID vaccine for ages 12 and up, approved by the U.S. Food and Drug Administration on Aug. 22, 2024. (Steven Decroos/Pfizer via AP)
Aug 27, 2025

FDA approves updated COVID-19 shots but limits access for some kids and adults

FDA narrows COVID-19 vaccine access, revokes Pfizer for under-5, and limits shots to high-risk adults and children.

Virus Outbreak Novavax Vaccine
Nov 3, 2021

‘A turning point’: US gives final clearance to COVID-19 shots for kids 5 to 11

U.S. health officials have given the final signoff to Pfizer’s kid-size COVID-19 shot, a milestone that opens a major expansion of the nation’s vaccination campaign to children as young as 5.

Virus Outbreak WHO Vaccines
Oct 29, 2021

FDA paves way for Pfizer COVID-19 vaccinations in young kids

The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer's COVID-19 vaccine.

Pfizer
Oct 26, 2021

FDA advisers back Pfizer’s COVID-19 vaccine for young kids

A panel of U.S. health advisers endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.

Virus Outbreak WHO Vaccines
Oct 7, 2021

Pfizer asks FDA to allow COVID shots for kids ages 5 to 11

Pfizer asked the U.S. government to allow use of its COVID-19 vaccine in children ages 5 to 11, potentially helping combat an alarming rise in serious infections in youngsters.

Virus Outbreak WHO Vaccines
Sep 20, 2021

Pfizer says COVID-19 vaccine works in kids ages 5 to 11

Pfizer said Monday that its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.

Virus Outbreak Vaccine Massachusetts
Aug 25, 2021

Pfizer seeking FDA OK for COVID-19 vaccine booster dose

Pfizer is seeking U.S. approval of a booster dose of its two-shot COVID-19 vaccine.

Virus Outbreak WHO Vaccines
Aug 25, 2021

From Disney World to Goldman Sachs, FDA move prompts vaccine mandates

A flurry of employers are requiring workers to get vaccinated against COVID-19 after the federal government gave full approval to the Pfizer shot.

Virus Outbreak Vaccine Massachusetts
Aug 23, 2021

Pfizer COVID-19 vaccine granted full approval by FDA, opening way for mandates

The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, a milestone that may help lift public confidence in the shots.

Greenberg, Lawrence
Aug 8, 2016

Carroll Co. man accepts plea deal in wife’s shooting, alleges violent behavior caused by Chantix

WESTMINSTER — A Carroll County man who claims a psychotic episode during which he shot his wife was caused by a reaction to the smoking cessation aid Chantix was released […]

Aug 10, 2015

FDA gives Baltimore firm’s drug ‘orphaned’ status

Gliknik Inc., a privately held biopharmaceutical company based in Baltimore, on Monday announced the FDA granted its autoimmune candidate drug GL-2045 orphan drug designation for Chronic Inflammatory Demyelinating Polyneuropathy, a […]